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The Ink4a/Arf locus encodes 2 tumor suppressor molecules, p16INK4a and Arf, which are principal mediators 
of cellular senescence. To study the links between senescence and aging in vivo, we examined Ink4a/Arf expres-
sion in rodent models of aging. We show that expression of p16INK4a and Arf markedly increases in almost all 
rodent tissues with advancing age, while there is little or no change in the expression of other related cell cycle 
inhibitors. The increase in expression is restricted to well-defined compartments within each organ studied 
and occurs in both epithelial and stromal cells of diverse lineages. The age-associated increase in expres-
sion of p16INK4a and Arf is attenuated in the kidney, ovary, and heart by caloric restriction, and this decrease 
correlates with diminished expression of an in vivo marker of senescence, as well as decreased pathology of 
those organs. Last, the age-related increase in Ink4a/Arf expression can be independently attributed to the 
expression of Ets-1, a known p16INK4a transcriptional activator, as well as unknown Ink4a/Arf coregulatory 
molecules. These data suggest that expression of the Ink4a/Arf tumor suppressor locus is a robust biomarker, 
and possible effector, of mammalian aging.
Introduction
Aging is a complex set of phenotypes characterized by reduced 
repair and/or regeneration of lost or damaged cells. Although 
studies in lower organisms have linked metabolism and the pro-
duction of oxygen radicals with the rate of aging (reviewed in ref. 
1), less is known about the molecular effectors of aging in mam-
mals. As opposed to homeostasis in organisms with a postmitotic 
soma, such as Drosophila and Caenorhabditis elegans, mammalian 
homeostasis depends on the persistent and obligate function of 
reservoirs of self-renewing tissue stem cells that are necessary for 
tissue regeneration. Therefore, regulators of stem cell longevity 
are thought to play a role in human aging (reviewed in ref. 2). 
In particular, mediators of senescence, an important tumor sup-
pressor mechanism and specialized form of growth arrest, have 
been suggested to play a role in aging by limiting the long-term 
growth of these self-renewing compartments (reviewed in refs. 3, 
4). For example, excess activity of p53 has been shown to induce 
premature aging in mice in multiple tissue types (5, 6). For these 
reasons, it has been argued that some aspects of aging may result 
from the beneficial, anticancer functions of mediators of senes-
cence such as p53, ARF, and p16INK4a.
We sought to examine the role of p16INK4a, ARF, and related cell 
cycle inhibitors in mammalian aging. This choice was motivated by 
the importance of p16INK4a and/or ARF in the senescence in vitro 
of many murine and human cell types, e.g., islets (7), fibroblasts 
(8, 9), keratinocytes (10, 11), and macrophages (12); the fact that 
expression of p16INK4a significantly accumulates with normal aging 
in rodents and humans in a variety of tissues (13–19); and the fact 
that p16INK4a and Arf appear to be principal mediators of stem cell 
longevity in vivo (20–24). Toward this end, we sought to define the 
pattern of expression of cell cycle inhibitors in aging rodents, and to 
determine the effects of known regulators of aging such as caloric 
restriction on the expression of these inhibitors of proliferation.
Results
Expression of Ink4a/Arf in vivo. We determined the expression of 
cyclin-dependent kinase inhibitor (CDKI) family members, which 
are principal regulators of the mammalian cell cycle (25). CDKIs 
inhibit the kinase activity of Cdk2, Cdk4, and Cdk6, thereby inhib-
iting phosphorylation of their target protein Rb and eliciting G1 
arrest. Eighteen quantitative real-time PCR strategies (Supple-
mental Table 1; supplemental material available at http://www.jci.
org/cgi/content/full/114/9/1299/DC1) were used to assay CDKI 
expression in tissues from old and young syngeneic adult rodents 
(Figure 1, A and B). We also tested the expression of Arf, a cell cycle 
inhibitor through its regulation of p53 stability, because Arf is 
coregulated with p16INK4a (Figure 1, A and B), and its expression has 
previously been shown to increase with aging in the mouse (18).
A marked increase (3-fold or greater) in the expression of p16INK4a 
was seen in 26 of 27 organs analyzed from 15 murine and 12 rat 
tissues. Particularly large (>30-fold) increases in relative terms of 
the ratio of RNA expression in old versus young tissues (old/young 
ratio) were seen in the murine cecum, kidney, ovary, and uterus (Fig-
ure 1A; log2 scale), while the highest expression in absolute terms 
was seen in lung, lymph node, adrenal, and uterus from aged ani-
mals (Figure 1B; log10 scale). The geometric mean of the old/young 
ratios among the 15 murine tissues analyzed was 9.7 (i.e., the aver-
age tissue demonstrated an approximately 10-fold increase in the 
expression of p16INK4a with aging). This value is likely an underes-
timate of the true average fold increase, because in tissues such as 
the pancreas and bone marrow (Figure 1A), p16INK4a expression was 
below the level of detection in young animals. Therefore, in these 
tissues, only a minimum estimate of the fold increase in expres-
sion in these tissues could be determined. Similarly, Arf expression 
increased severalfold in most of the tissues examined, particularly 
heart, duodenum, kidney, and uterus (Figure 1, A and B). The geo-
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metric mean of the Arf old/young ratios was a 3.5-fold increase, 
while the next highest cell cycle inhibitor, p21CIP, demonstrated only 
a 1.4-fold average increase. These data do not exclude a specific role 
for another CDKI in a particular tissue; for example, p15INK4b showed 
an approximately 5-fold increase in expression in the heart with 
aging. Likewise, our data do not exclude the possibility that certain 
of the CDKIs (e.g., p18INK4c [ref. 26] or p27KIP [ref. 27]) are regulated 
predominantly in a posttranscriptional manner with aging. None-
theless, Ink4a/Arf upregulation appears to be a strong correlate to 
organismal aging across many tissue types, and this marked and 
widespread upregulation is unique among the major in vivo inhibi-
tors of the mammalian cell cycle.
In terms of absolute transcript number and protein expression, 
the expression of p16INK4a and Arf was considerably lower in tissues 
from aged mice than in primary cultures of murine embryo fibro-
blasts (Figure 1B), even at passage 4 (less than 14 days in vitro). This 
observation emphasizes that the act of culture itself potently induc-
es the Ink4a/Arf locus (28) but also suggests that in vivo Ink4a/Arf 
Figure 1
Expression of the Ink4a/Arf locus increases with aging. (A) Relative expression. The ratios (log2 scale) of the expression of cell cycle inhibitors 
— old (26 months)/young (2.5 months) — from 15 tissues is graphed ± SEM. Each estimate represents the mean of 8–32 quantitative RT-PCR 
reactions on independent RNA samples derived from 4–6 mice. *Minimum estimate of old/young ratio. (B) Absolute expression. The absolute 
copy number of p16INK4a and Arf mRNA molecules (log10 scale) per 90 ng total RNA RT-PCR from 15 tissues of young (2.5 months) and old (26 
months) mice is graphed ± SEM. Murine embryo fibroblasts (MEFs) at early (P4) and late (P7) passage are shown for comparison. #Maximum 
estimated expression is indicated, as expression was below the level of detection.
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expression increases only in a relatively small subset of cells within 
a given tissue (e.g., the β cells of the pancreas; Figure 2A and ref. 
17). To determine in which organ compartments the expression 
of Ink4a/Arf increased, we performed additional lines of analysis 
including immunohistochemistry (IHC) and mRNA quantifica-
tion in purified populations of sorted cells (Figure 2, A and B, and 
data not shown). Using these approaches, we were able to define the 
compartmental expression of p16INK4a and/or Arf in selected tissues 
from aging rodents (summarized in Table 1).
This analysis led to several conclusions. First, there was a good 
correlation in most tissues between mRNA expression and pro-
tein expression. An exception, however, was the lung, where RNA 
expression of p16INK4a even from young mice was higher in absolute 
terms than in several tissues from old mice (Figure 1B) yet protein 
expression was not detected by IHC or immunoprecipitation–
Western analysis (not shown). This result could be attributable 
to either translational regulation of p16INK4a (29) or decreased 
protein stability in this tissue. Furthermore, we detected p16INK4a 
expression in a variety of cell types, including lining epithelium 
(e.g., of the renal cortex), mesenchyme (of the uterus), lympho-
cytes (in the spleen and lymph nodes), and specialized endocrine 
secretory tissues (e.g., pancreatic islet and adrenal) (Figure 2, A 
and B; Table 1). For example, in the uterus, 
there was marked expression of p16INK4a in the 
stroma of aged mice, but less so by IHC in the 
uterine epithelium. In the kidney, a marked 
increase in expression was noted in the cortical 
tubules, with detectable, but significantly less, 
expression in the medulla and glomeruli. In the 
spleen, increased expression of p16INK4a in both 
the stromal (red pulp) and lymphocyte (white 
pulp) compartments was noted, although this 
was higher in stroma (Figure 2, A and B). In 
aggregate, these data suggest that the expres-
sion of p16INK4a mRNA and protein increases in 
cells of varied histogenetic origins with aging. 
These results indicate that expression of the 
Ink4a/Arf locus can be induced in many if not 
most cell types in vivo, as would be suggested 
by related in vitro observations (7–12), as well 
as by the locus’s role in the suppression of a 
wide variety of cancer types (30).
To permit quantification of the compartmental expression of 
p16INK4a, hematopoietic organs were harvested and specific cell 
types purified (Figure 2B). Expression of p16INK4a increased with 
aging in both the stromal and the cellular (predominantly T cell) 
compartments of lymph nodes, but to a greater degree in the 
stroma (42-fold vs. 13-fold). Similarly, both the stromal and the 
cellular compartments of the spleen showed increased expression 
of p16INK4a with aging (15-fold vs. 5-fold). Among the splenic cellu-
lar elements, the predominant increases were seen in lymphocytes 
(B220+, 48% of total splenic cells) and cells that did not express 
B lymphocyte or myeloid markers (double negative for Mac1 
and B220, 22% of cells), whereas little increase was seen in the 
myeloid compartment (Mac1+, 9% of cells). Lastly, we compared 
the expression of p16INK4a and Arf in lineage-negative (2%) versus 
lineage-positive (98%) bone marrow cells. In this compartment, 
the principal increase in expression was in lineage-negative cells, 
which are enriched for hematopoietic stem and progenitor cells 
(HSPCs) (31). This finding is consistent with the reported role of 
Ink4a/Arf expression in HSPCs and early committed progenitors 
from adult mice (21). Therefore, Ink4a/Arf can be expressed in 
several cell types of hematopoietic organs, including stromal ele-
ments, lymphocytes, and progenitor cells.
Figure 2
p16INK4a expression in specific compartments by 
immunohistochemistry and cell purification. (A) 
Immunoperoxidase staining performed on paraf-
fin-embedded sections of germ-line p16INK4a-defi-
cient (KO), WT young (3.5 months), and WT old 
(25 months) murine tissues using an anti-p16INK4a 
antibody. Positively staining cells demonstrate both 
nuclear and cytoplasmic expression. GC, germinal 
center. (B) Relative expression ratios (old/young, 
log2 scale) of p16INK4a in specific compartments 
(average purity >94% for all fractions) of bone 
marrow (lin–, 2%; lin+, 97%), spleen (B220+, 48%; 
Mac1+, 9%; B220–Mac1–, 22%), and lymph node. 
Asterisks indicate that p16INK4a expression was 
undetectable in these cell populations from young 
mice, and therefore a minimum estimate of the fold 
increase is shown.
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Caloric restriction retards p16INK4a accumulation. Caloric restriction 
(CR) retards aging in many species, but the molecular effectors of 
this are unknown (32). To examine the effects of CR on p16INK4a 
expression, we harvested total RNA from organs from calori-
cally restricted (CR) and ad libitum–fed (AL) Fischer 344 (F344) 
rats (Supplemental Figure 1, A and B) (33). We confirmed that 
Ink4a/Arf expression increased with aging in 12 different tissues 
from AL rats (representative data shown in Figure 3A). There 
was excellent concordance in the fold increase of Ink4a/Arf and 
p21CIP expression between mouse and rat tissues from AL ani-
mals, except in the testis. In murine testis, no increase in p16INK4a 
was seen (Figure 1, A and B), whereas in rat testis, a greater-than-
135-fold increase in p16INK4a expression was noted (Figure 3A). 
A histologic examination of rat testis from old AL males, how-
ever, demonstrated marked involvement with Leydig cell tumor 
(Supplemental Figure 1C), which occurs spontaneously in the 
majority of AL F344 rats greater than 24 months of age (34), 
and which highly expresses p16INK4a (not shown). Increases in Arf 
expression similar in magnitude to those in the mouse were also 
noted across this panel of tissues, as were more modest increases 
in p21CIP (Figure 3A). Therefore, mice and rats appear to age simi-
larly with respect to Ink4a/Arf expression.
When compared with tissues from AL animals, several, but 
not all, tissues from CR animals showed marked reductions in 
the age-induced increase of Ink4a/Arf expression. A 2- to 16-fold 
attenuation in the age-induced expression of p16INK4a was seen in 
adrenal, heart, kidney, ovary, and testis; but CR did not attenuate 
Ink4a/Arf expression in the lung, lymph node, spleen, and liver 
(Figure 3A). Unexpectedly, in the uterus, CR appeared to induce 
a significant increase in Ink4a/Arf expression with aging. Consis-
tent with a previous report (34), we noted that aged CR males 
demonstrated greatly reduced Leydig cell hyperplasia (Supple-
mental Figure 1C) compared with AL animals. Correspondingly, 
this decreased tumor burden correlated with a marked reduction 
in the age-induced increase in p16INK4a expression (135-fold in AL 
rats vs. 58-fold in CR rats). Therefore, the decrease in p16INK4a 
expression with CR in aged rat testis likely results from an 
antineoplastic effect of CR. In contrast, the marked decrease in 
p16INK4a expression in the cortical tubules of the kidney (Figure 
3B) from CR animals correlated with decreased nephritis (not 
shown), a chronic disease seen with nearly complete penetrance in 
aged F344 rats and a principal limit to the longevity of this strain 
(34). Therefore, in both of these tissues, the decrease in Ink4a/Arf 
expression occurred in concert with a CR-induced reduction of 
a disease state, suggesting that increased Ink4a/Arf expression 
in some circumstances may predispose to organ pathology, pre-
saging organ failure and death. These observations also predict 
that tissue-specific increases in Ink4a/Arf expression with aging 
likely will vary among mammals (and even across inbred strains 
of rodents) to reflect specific predispositions to disease resulting 
from unshared genetics and/or environmental exposures.
We also tested the relationship of Ink4a/Arf expression 
with other aging models. Several single-gene mutations that 
decrease IGF-1 extend longevity (reviewed in ref. 35), through 
a mechanism that appears at least partially distinct from CR 
(36). We tested Ink4a/Arf expression in both lung and kidney 
from old and young growth hormone receptor+/+ (GHR+/+) and 
GHR–/– mice (37) that had been fed ad libitum or CR diets. The 
age-induced expression of Ink4a/Arf in mice from this cohort 
of mixed genetic background was more heterogeneous than in 
either the inbred F344 rat or the C57BL/6 mouse cohort (Sup-
plemental Figure 2). Nonetheless, in accord with our obser-
vations in the rat, CR significantly reduced p16INK4a and Arf 
expression in the murine kidney (Supplemental Figure 2). GHR 
deficiency, however, had no effect on p16INK4a or Arf expression 
in the kidney, although modest reductions in p16INK4a and Arf 
expression were noted in the lung from GHR-deficient animals 
(Supplemental Figure 2). These results confirm in another spe-
cies the effect of CR on Ink4a/Arf expression in the kidney and 
also suggest that GHR deficiency and CR enhance longevity by 
molecularly distinct mechanisms in distinct tissues, as has been 
suggested by other methodologies (36, 38).
Furthermore, we sought to determine the functional signifi-
cance of Ink4a/Arf expression in aging mammals. We used a well-
Table 1
Expression of p16INK4a in murine tissues (present work) as compared with published human IHC data
Tissue Fold  Abs. exp.  mRNA expression  IHC in mouse IHC in human 
 increase in old organA (by sorting or in situ)  (present work) (ref.)
Adrenal 7.6 2,027 ND ND ND
Bone marrow >9.7 366 +++ Lin– cells, ++ Lin+ cells ND Rare + macrophages, plasma cells (17)
Cecum >70.2 267 ND ND Not detected (17)
Cortex 9.2 235 ND ND Not detected (17)
Duod. >17.0 27 ND ND ND
Heart 7.2 1,064 Not detected ND Myocardium (63)
Kidney >34.5 220 ND +++ Cortical tubules;  Cortical tubules, rare glomeruli 
    tr. glomeruli (13, 16)
Liver 29.4 447 ND ND Not detected (17)
Lung 3.2 2,714 +++ Small bronchi, + alveoli Not detected Rare + alveolar cells (17)
Lymph node 15.3 4,146 ++++ Stroma, +++ lymphocytes ND ND
Ovary 30.5 1,514 ND +++ Stroma Not detected (17)
Panc. >4.5 11 ND Islets Islets (17)
Spleen 3.3 1,357 ++++ Stroma, ++ lymphocytes ++++ Stroma, ++ lymphocytes Stroma (17)
Testis 1.1 976 + Leydig cells, +++ epididymis ND in mouse; Leydig cells in rat Epididymis (17)
Uterus 96.0 2,140 ++ Stroma and epithelium ++++ Stroma, tr. epithelium Epithelium and stroma (17)
Abs. exp., absolute expression; ND, not determined; Duod., duodenum; Panc., pancreas; tr., trace. ACopies per 90 ng total RNA.
research article
 The Journal of Clinical Investigation   http://www.jci.org   Volume 114   Number 9   November 2004 1303
described in vivo marker of senescence, senescence-associated 
β-galactosidase (SA-β-gal) expression, a high-pH galactosidase 
activity detectable in senescent cells and tissues (39). This assay 
was limited in most tissues (e.g., liver and spleen) because of high 
background activity but was interpretable in both murine and rat 
kidney (Figure 3C), in accord with a previous report (15). A sig-
nificant increase in SA-β-gal activity was detected in aging kidney 
from AL mice and rats (Figure 3C) and was predominantly restrict-
ed to the renal cortex, a pattern of expression that overlapped with 
p16INK4a expression. This increase in SA-β-gal activity was, like the 
increase in p16INK4a expression, abolished by CR, which suggests 
that Ink4a/Arf–induced senescence is induced in the renal cortex 
as a result of increased metabolism.
Ets-1 and a common Ink4a/Arf regulator modulate p16INK4a expression 
with aging. In an effort to determine the factors responsible for the 
marked accumulation of Ink4a/Arf with aging, we next determined 
the expression of 3 principal regulators of Ink4a/Arf expression: 
Ets-1, an activator of p16INK4a (40, 41); Id1, a transcriptional repres-
sor of p16INK4a (40, 42); and Bmi-1, a repressor of the Ink4a/Arf 
locus (43) (Supplemental Figure 3). 
The expression of these genes was 
determined across multiple tissues 
from young and old mice and/or 
rats, with and without CR. We cal-
culated Pearson correlation coeffi-
cients of the log-transformed old/
young ratios of all genes across the 
tissue types analyzed. As expected, 
we found a high correlation between 
p16INK4a and Arf expression (r = 0.75, 
P < 0.0001) and a modest correla-
tion between Arf and p21CIP (r = 0.37, 
P = 0.03), but no significant corre-
lation between p16INK4a and p21CIP. 
These results are consistent with the 
known transcriptional relationships 
of these genes; in particular, several 
proteins (43–47) have been identi-
fied that coordinately regulate the 
expression of both Ink4a/Arf prod-
ucts, and Arf regulates p53 activ-
ity, which in turn induces p21CIP 
expression. Unexpectedly, we found 
a high correlation between p18INK4c 
and p19INK4d (r = 0.68, P = 0.002), 
which suggests that these genes are 
regulated by common or related 
transcriptional elements. Although 
these homologous INK4s are con-
comitantly expressed in many tis-
sues (18), we are not aware of pre-
vious data showing coordinated 
expression in vivo.
The expression of Ink4a/Arf regu-
lators was next considered (Supple-
mental Figure 3). A weak negative 
correlation was found between 
the expression of Id1 and that of 
p16INK4a (r = –0.40, P = 0.07), con-
sistent with Id1’s known role as a 
transcriptional repressor of p16INK4a (40, 42). No significant cor-
relation was seen between Bmi-1 expression and that of either 
p16INK4a or Arf (not shown). Remarkably, however, a strong cor-
relation was noted between p16INK4a and Ets-1 (r = 0.62, P < 0.001; 
Figure 4A), but not between Arf and Ets-1 (r = 0.15, P = 0.40). This 
observation is consistent with the finding that Ets-1 induces the 
expression of p16INK4a, but not Arf, in cultured cells (40, 41) and 
suggests that a significant component of the in vivo variance in 
p16INK4a expression with aging (r2 = 0.38) results from transcrip-
tional activation by Ets-1 (Figure 4B). Moreover, a reduction in 
Ets-1 expression was seen in the kidney of CR rats and mice (Fig-
ure 3D), which suggests that increased metabolism is upstream 
of Ets-1 activation in the aging kidney. Similarly, the strong cor-
relation between p16INK4a and Arf also suggests that an unknown 
coregulator(s) of p16INK4a and Arf exerts a powerful effect 
(r2 = 0.49) on the expression of both Ink4a/Arf products with 
aging, and that this coregulator(s) must be independent of 
Ets-1 (as Arf and Ets-1 are not correlated). Therefore, the in vivo 
expression of p16INK4a in aging appears to reflect almost equally 
Figure 3
Effects of caloric restriction and GHR deficiency on gene expression and aging. (A) Relative expres-
sion ratios (old/young, log2 scale) of cell cycle inhibitors in 7 tissues derived from old (28 months) and 
young (3 months) AL or CR F344 rats. The relative ratios are graphed ± SEM. Each estimate repre-
sents the mean of 8–16 quantitative RT-PCR reactions on independent RNA samples derived from 4 
rats. (B) Immunoperoxidase staining on paraffin-embedded kidney sections from young, old AL, and 
old CR F344 rats using an anti-p16INK4a antibody. G, glomeruli seen in cortical sections. (C) SA-β-gal 
staining in AL and CR mouse and rat kidney. C, renal cortex; M, renal medulla. Thin tissue slices 
were stained for mice, as opposed to small tissue wedges for rats. SA-β-gal activity is predominantly 
restricted to the renal cortex. (D) Relative expression ratios (old/young, log2 scale) of Ets-1 in kidneys 
derived from AL and CR rats and mice. Results from the kidneys from AL and CR mice with and with-
out GHR deficiency are also shown. Each estimate represents the mean of 8–32 quantitative RT-PCR 
reactions on independent RNA samples derived from 8 mice or 4 rats.
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a p16INK4a-specific effect that correlates with Ets-1 expression, and 
an independent, Ink4a/Arf coregulatory effect.
Discussion
This work adds to a growing body of evidence suggesting that in 
vivo senescence, induced by Ink4a/Arf expression, plays a causal 
role in the aging of certain tissue types. First, as shown in this 
work, Ink4a/Arf expression is not only tightly linked with aging 
but is influenced by CR and correlates with SA-β-gal expression. 
Ink4a/Arf expression has also been shown to increase in several tis-
sues in a murine model of premature aging (48), and expression 
of p16INK4a or Ink4a/Arf correlates in vivo with impaired prolifera-
tion and failure of hematopoietic stem cells (20, 21, 23, 24). While 
the functional consequences of Ink4a/Arf expression in aging tis-
sues are an area of active investigation, p16INK4a deficiency has been 
shown to ameliorate an age-related decline in T cell responsiveness 
to CD3 and CD28 (49), a hallmark of aging in the murine immune 
system (50). Similarly, neural stem cells from Bmi-1–deficient ani-
mals demonstrate increased Ink4a/Arf expression and impaired 
regenerative potential; and this phenotype can be partially rescued 
by p16INK4a deficiency (22). In aggregate, these results suggest that 
p16INK4a and/or Arf expression is not merely a biomarker, but also 
an effector, of aging, presumably by limiting the self-renewal capac-
ity of disparate tissues including at least lymphoid organs, bone 
marrow, and brain. Further determination of the functional role 
of the Ink4a/Arf locus in other aging tissues, as well as the relative 
contribution p16INK4a versus Arf, will require further study of mice 
with germ-line and tissue-specific deletion of p16INK4a and/or Arf.
We detected a significant attenuation of age-induced Ink4a/Arf 
expression by CR in several tissues, but particularly in the kidney, 
where the effect was nearly complete. The reduction in Ink4a/Arf 
expression correlated with decreased nephritis in aged F344 rats, a 
major limit of longevity in this strain (34). Therefore, it is tempting 
to speculate that Ink4a/Arf expression limits the ability of aged kid-
ney to self-repair, resulting in organ failure and death. Our analysis 
of tissue from GHR-deficient animals was too limited to determine 
the effects, at the organismal level, of GHR deficiency on Ink4a/Arf 
expression; but in contrast to CR, GHR loss was not seen to affect 
p16INK4a expression in the aging kidney (Supplemental Figure 2). It 
is possible that reductions in IGF-1 similarly retard the increase in 
Ink4a/Arf expression in other tissues; this would explain the abil-
ity of CR to extend the longevity of IGF-1–deficient animals (36). 
Alternatively, IGF-1 deficiency may work through a distinct, Ink4a/
Arf–independent mechanism to retard aging.
As rodents have large telomeres and promiscuously express 
telomerase (51, 52), the signal that induces Ink4a/Arf–mediat-
ed senescence in the kidney and other organs is not likely to be 
telomere-based. We were, however, able to demonstrate a strong 
correlation between Ets-1 expression and p16INK4a expression with 
aging across 27 different tissues from 2 species, with and without 
CR. Given that Ets-1 is a direct transcriptional activator of p16INK4a 
in vitro (40, 41), these data suggest that Ets-1 is a principal deter-
minant of p16INK4a expression with aging in vivo. Ets-1, in turn, is 
regulated by a variety of stress-related signals and, in particular, 
MAPK activity. Ets-1 activation has been linked to both ERK (53, 
54) and p38MAPK (55) signaling, while recent genetic evidence has 
shown that p38MAPK activation is associated with increased Ink4a/
Arf expression in vivo (56). These observations are consistent with 
the model (Figure 4B) that presently unidentified stresses activate 
Ets-1 via MAPK pathways to induce a p16INK4a-mediated senes-
cence in aging organisms.
By statistical methods, we additionally inferred the existence 
of an unknown coregulatory factor(s) that is distinct from Ets-1 
and that modulates the expression of both p16INK4a and Arf with 
aging. An obvious candidate is the Polycomb group (PcG) pro-
tein Bmi-1, which has been shown to regulate p16INK4a and Arf 
expression in stem cells in vivo (20–22, 57). We did not, however, 
detect a negative correlation between Bmi-1 expression and either 
p16INK4a or Arf in most aging tissues. Therefore, transcription of 
Bmi-1 is not likely to be a predominant regulatory mechanism 
of Ink4a/Arf expression in vivo across multiple tissue types, but 
this analysis does not exclude a specific role for Bmi-1 in a par-
ticular tissue. Along these lines, we detected greater-than-2-fold 
decreases in Bmi-1 expression with aging in spleen and bone 
marrow (Supplemental Figure 3), which suggests that perhaps 
Bmi-1–containing PcG complexes are of particular importance in 
repressing Ink4a/Arf expression in hematopoietic tissues, as has 
been suggested (20, 21, 43). Likewise, it is possible that related 
Figure 4
p16INK4a expression with aging strongly correlates with Arf and Ets-1 
expression. (A) A scatter plot (log2 scale, both axes) of the ratios (old/
young) of p16INK4a expression versus the expression ratios (old/young) 
of Arf, Ets-1, and Id1 seen in the corresponding tissue (n = 22–70 data 
pairs per gene from up to 15 tissues in both mouse and rat). Each 
ratio represents a mean value of multiple measurements per tissue as 
described in Methods. A best-fit line determined by linear regression 
is shown for each data series, with Pearson correlation coefficient and 
2-tailed P value. No significant correlation was seen between Arf and 
Ets-1, or between Arf or p16INK4a and Bmi-1 (not shown). (B) Arrows 
show known or inferred transcriptional relationships, and numbers indi-
cate the covariances (r2) for the linked elements as determined in A. 
As p16INK4a and Arf do not regulate one another, it seems reasonable 
to assume that an unknown coregulator (X) modulates the expres-
sion of both transcripts with aging, explaining their strong correlation 
(r2 = 48%). Furthermore, as Arf and Ets-1 do not covary, X and Ets-1 
must be independent. X need not represent a single transcription fac-
tor: it may represent the combined activity of several genes (e.g., the 
PcG family members) or genes that affect other transcript properties, 
such as message stability. This model suggests that the majority (87%) 
of the variance in p16INK4a expression with aging in the analyzed tis-
sues can be attributed to the activity of X and Ets-1.
research article
 The Journal of Clinical Investigation   http://www.jci.org   Volume 114   Number 9   November 2004 1305
Ink4a/Arf–repressing PcG family members such as Cbx7 (58) or 
Mel18 (59) subsume the function of Bmi-1 in other tissues; that 
PcG complex activity is regulated post-transcriptionally; or that 
unidentified non-PcG molecules are important coregulators of 
Ink4a/Arf. In this regard, it will also be of future interest to deter-
mine the links, if any, between Ink4a/Arf expression and known 
regulators of aging such as Foxo proteins and SirT1 (60, 61).
A molecular biomarker of physiologic, as opposed to chronologic, 
age is needed in clinical medicine. While other molecular markers 
of aging have been suggested, we believe the analysis of INK4a/ARF 
expression may prove particularly fruitful in this regard, for several 
reasons. First, the change in p16INK4a expression with aging is large 
— over 10-fold in many tissues — and relatively simple to measure 
by either immunohistochemical methods or quantitative real-time 
PCR analysis. For example, there is a clinically validated, commer-
cially available kit (DakoCytomation Inc.) for use in the detection 
of p16INK4a expression, and many anatomic pathologists are already 
comfortable with the interpretation of p16INK4a IHC. Moreover, 
our results demonstrate that Ink4a/Arf can be expressed in many 
cell types in response to age-induced stresses, and that Ink4a/Arf 
expression changes in at least a subcompartment of the majority 
of mammalian organs with aging. For this reason, p16INK4a or ARF 
expression may be a particularly robust marker of aging, useful for 
the study of many cell types in disparate organs. Lastly, given the 
probable causal role of p16INK4a and/or ARF in aging, expression of 
INK4a/ARF should be a stronger correlate of aging than expression 
of other genes whose expression is merely epiphenomenal.
One anticipates that a well-defined molecular marker of aging 
could be used for at least 4 clinical purposes: (a) to facilitate the 
forecasting of disease progression in premorbid syndromes such as 
renal insufficiency and cardiomyopathy; (b) to provide a surrogate 
marker for efficacy of anti-aging therapeutics; (c) to predict future 
toxicity from noxious therapies such as chemo- or radiotherapy and 
surgery that require tissue regeneration and repair; and (d) to deter-
mine donor suitability for bone marrow, solid organ, and tissue 
allografts. The utility of INK4a/ARF expression in predicting, and 
perhaps determining, a tissue’s future regenerative potential — i.e., 
indications (c) and (d) above — is a topic of active, ongoing study. 
This work, however, does serve as “proof of principle” for the use 
of Ink4a/Arf expression for indications (a) and (b): we demonstrate 
that Ink4a/Arf expression correlates with tissue aging and altera-
tions in disease progression in the rodent kidney and testis, and 
that reduced expression of the locus correlates with response to an 
anti-aging therapy, caloric restriction. Therefore, our data suggest 
that the measurement of INK4a/ARF expression may similarly be of 
clinical benefit in the determination of human physiologic age.
Methods
Animals. All animals were housed and treated in accordance with protocols 
approved by the institutional care and use committee for animal research 
at the University of North Carolina. All murine analyses were performed in 
C57BL/6 mice unless otherwise mentioned. For cell sorting experiments, 
22- to 25-month-old mice of mixed genetic background (C57BL/6 × NIH 
Black Swiss; from Yue Xiong, University of North Carolina) were analyzed. 
Old (21 months) and young (5 months) GHR KO and WT (CR and AL) 
mice of mixed genetic background (derived from Ola-BALB/c, C57BL/6, 
and C3H; courtesy of John Kopchick, Ohio University, Athens, Ohio, 
USA) were analyzed. CR for this murine cohort was done as previously 
described (38). Aged rodents were obtained from the aged-rodent colonies 
of the National Institute on Aging (ref. 33; see also http://www.nia.nih.
gov/research/rodent.htm) and euthanized at our facility, and organs were 
harvested as described below. For murine studies, old (25–26 months) and 
young (2.5–3.5 months) C57BL/6 mice (3 males and 3 females) were ana-
lyzed. For CR experiments, old (28 months) and young (3 months) F344 AL 
rats (2 old and 2 young males, 2 old and 2 young females) were obtained, as 
well as old (28 months) CR littermates (2 males and 2 females).
Animals were euthanized by CO2 inhalation, and organs were harvested. 
Organs were grossly dissected free of contaminating tissue (e.g., adipose) 
and then snap-frozen. RNA was harvested from a matched portion of the 
organ (e.g., the superior half of the kidney) in all instances to assure that 
results did not differ because of organ composition. For RNA analysis, tis-
sues were collected after cardiac perfusion with RNAlater (Ambion Inc.) or 
after snap-freezing in liquid nitrogen. For IHC and H&E staining, organs 
were harvested and fixed as described below, and then stored in 70% etha-
nol until paraffin embedding.
Quantitative real-time PCR. Total RNA was extracted from tissues, serially 
passaged murine embryo fibroblasts (each passage corresponds to 3 days 
in vitro), or sorted cell samples using a QIAGEN RNeasy RNA isolation kit 
according to the manufacturer’s instructions. Transcription into cDNA 
was done in a 20-μl volume using oligo-dT(12-18) or random hexamer and 
ImProm-II reverse transcriptase (Promega Corp.) according to the manu-
facturer’s instructions. All PCR reactions were carried out in a final volume 
of 20 μl and were performed in duplicate for each cDNA sample in the ABI 
PRISM 7700 Sequence Detection System (Applied Biosystems) according 
to the manufacturer’s protocol. All experiments were done on organs from 
at least 2 different animals in each group (old vs. young, CR vs. AL).
Sequence-specific primers and probe were designed using Primer Express 
(Applied Biosystems) for the indicated genes (Supplemental Table 1). Oli-
gonucleotide primers and probes were synthesized by MWG Biotech. All 
primer sets were designed to span an intron. Predeveloped assays were pur-
chased from Applied Biosystems for the additionally listed murine and 
rat genes (Supplemental Table 1). The reaction mix consisted of Univer-
sal Master Mix No AmpErase UNG (Applied Biosystems), 0.25 μM fluo-
rogenic probe, 0.9 μM of each specific forward and reverse primer, and 
9 μl of diluted cDNA (equivalent to ∼90 ng total RNA). Amplifications 
were done under standard conditions. The number of PCR cycles needed 
to reach the fluorescence threshold was determined in duplicate for each 
cDNA, averaged, and then normalized to at least 1 reference gene (18S, 
GAPDH, or TATA-binding protein [TBP]; see Supplemental Figure 4 for 
further details) to yield the cycle number at which fluorescence threshold 
was reached (Ct). The ratio of expression in old versus young tissues (old/
young) was determined as 2[Ct(old) – Ct(young)]; therefore, log2(old/young) = 
Ct(old) – Ct(young). Ratios were log-transformed for calculations of SE and 
Pearson correlation coefficients using Prism software (GraphPad Software 
Inc.). For absolute quantification of transcript copy number for p16INK4a, 
p15INK4b, p19ARF, p21CIP, p18INK4c, and p19INK4d, the fragment of interest was 
cloned and a standard curve generated with serial 4-fold dilutions (Supple-
mental Figure 5). For all assays tested, the PCR reaction was linear over the 
range studied (19–40 cycles of amplification; Supplemental Figure 5). If 
Ct was not reached by 40 cycles, expression was considered below the limit 
of detection. All RT-PCR reactions gave a single band when analyzed by 
gel electrophoresis, and all reactions used a fluorochrome-labeled internal 
probe to enhance sensitivity and specificity.
Cell sorting of bone marrow, lymph node, thymus, and spleen. Tissues from 5- and 
22-month old mice (n = 2 per age) were disaggregated and sorted. For bone 
marrow, lineage-negative and lineage-positive fractions were collected using a 
lineage cell depletion kit with an autoMACS Separator (Miltenyi Biotec Inc.) 
according to the manufacturer’s protocol. Stromal and cell components for 
lymph node, thymus, and spleen were prepared by pressing between frosted 
glass slides, followed by washing with PBS containing 10% FCS. Splenocytes 
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were then further analyzed after red blood cell lysis by staining with anti-
B220 (Caltag Laboratories Inc.) and anti-CD11b (Mac1; Caltag Laboratories 
Inc.) mAbs for 30 minutes on ice followed by washing. Cells were sorted by 
MoFlo (Cytomation Inc.) to B220+, Mac1+, and B220–Mac1– populations 
(purity >94%) at the University of North Carolina FACS Core facility.
IHC and SA-β-gal staining. To determine optimal IHC staining conditions 
for p16INK4a, tissues were harvested from age-matched littermate p16INK4a+/+ 
and p16INK4a–/– mice and analyzed. After empiric testing of several fixatives 
as previously described (62), Fekete’s acid alcohol solution (61% ETOH, 
4.3% glacial acetic acid, and 3.5% formalin) was determined to be optimal 
for p16INK4a IHC staining in mouse and rat tissues using a commercially 
available antibody and kit (ImmunoCruz HRP kit with F-12 antibody, 
sc-1661; Santa Cruz Biotechnology Inc.). Five-micron paraffin sections 
were cut and underwent steam citrate antigen retrieval, hybridization per 
the manufacturer’s protocols, and hematoxylin counterstaining. Sections 
were examined by an observer blinded to animal age, diet, and genotype. SA- 
β-gal staining was performed as previously described (15, 39, 43). In brief, 
thin sections (<2 mm) of harvested organs were fixed at room temperature 
for 15 minutes in 0.5% glutaraldehyde/PBS (pH 6.0). After fixation, organ 
slices were washed twice in PBS (pH 6.0), stained overnight at 37°C in SA-
β-gal buffer (1 mg/ml X-gal, 5 mM potassium ferricyanide, 5 mM potas-
sium ferrocyanide, and 1 mM MgCl2 in PBS, pH 6.0), and photographed 
with a high-resolution CCD camera (LighTools Research).
Acknowledgments
We wish to thank John Kopchick, Nancy Nadon, Igor Mikaelian, 
Richard Falvo, Scott Alson, Balfour Sartor, and Yue Xiong for 
advice and reagents; and Andrzej Bartke, Diego Castrillon, and 
Ron DePinho for comments on the manuscript. This work was 
supported by grants from the Sidney Kimmel Foundation for Can-
cer Research, the Paul Beeson Physician Scholars program, and the 
NIH (AG19899 and CA090679).
Received for publication June 18, 2004, and accepted in revised 
form July 27, 2004.
Address correspondence to: Norman E. Sharpless, The Lineberger 
Comprehensive Cancer Center, Campus box no. 7295, Depart-
ments of Medicine and Genetics, The University of North Caro-
lina School of Medicine, Chapel Hill, North Carolina 27599-7295, 
USA. Phone: (919) 966-1185, or (919) 966-4067; Fax: (919) 966-
8212; E-mail: nes@med.unc.edu.
 1. Guarente, L., and Kenyon, C. 2000. Genetic path-
ways that regulate ageing in model organisms. 
Nature. 408:255–262.
 2. Park, I.K., Morrison, S.J., and Clarke, M.F. 2004. 
Bmi1, stem cells, and senescence regulation. J. Clin. 
Invest. 113:175–179. doi:10.1172/JCI200420800.
 3. Campisi, J. 2003. Cancer and ageing: rival demons? 
Nat. Rev. Cancer. 3:339–349.
 4. Sharpless, N.E., and DePinho, R.A. 2002. p53: good 
cop/bad cop. Cell. 110:9–12.
 5. Artandi, S.E., et al. 2000. Telomere dysfunction 
promotes non-reciprocal translocations and epi-
thelial cancers in mice. Nature. 406:641–645.
 6. Tyner, S.D., et al. 2002. p53 mutant mice that dis-
play early ageing-associated phenotypes. Nature. 
415:45–53.
 7. Halvorsen, T.L., Beattie, G.M., Lopez, A.D., Hayek, 
A., and Levine, F. 2000. Accelerated telomere 
shortening and senescence in human pancreatic 
islet cells stimulated to divide in vitro. J. Endocrinol. 
166:103–109.
 8. Alcorta, D.A., et al. 1996. Involvement of the 
cyclin-dependent kinase inhibitor p16 (INK4a) in 
replicative senescence of normal human fibroblasts. 
Proc. Natl. Acad. Sci. U. S. A. 93:13742–13747.
 9. Kamijo, T., et al. 1997. Tumor suppression at the 
mouse INK4a locus mediated by the alternative 
reading frame product p19ARF. Cell. 91:649–659.
 10. Kiyono, T., et al. 1998. Both Rb/p16INK4a inactiva-
tion and telomerase activity are required to immor-
talize human epithelial cells. Nature. 396:84–88.
 11. Rheinwald, J.G., et al. 2002. A two-stage, 
p16(INK4A)- and p53-dependent keratinocyte 
senescence mechanism that limits replicative 
potential independent of telomere status. Mol. Cell. 
Biol. 22:5157–5172.
 12. Randle, D.H., Zindy, F., Sherr, C.J., and Roussel, 
M.F. 2001. Differential effects of p19(Arf) and 
p16(Ink4a) loss on senescence of murine bone 
marrow-derived preB cells and macrophages. Proc. 
Natl. Acad. Sci. U. S. A. 98:9654–9659.
 13. Chkhotua, A.B., et al. 2003. Increased expression 
of p16 and p27 cyclin-dependent kinase inhibitor 
genes in aging human kidney and chronic allograft 
nephropathy. Am. J. Kidney Dis. 41:1303–1313.
 14. Kajstura, J., et al. 2000. Telomere shortening is an 
in vivo marker of myocyte replication and aging. 
Am. J. Pathol. 156:813–819.
 15. Melk, A., et al. 2003. Cell senescence in rat kidneys 
in vivo increases with growth and age despite lack 
of telomere shortening. Kidney Int. 63:2134–2143.
 16. Melk, A., et al. 2004. Expression of p16INK4a and 
other cell cycle regulator and senescence associ-
ated genes in aging human kidney. Kidney Int. 
65:510–520.
 17. Nielsen, G.P., et al. 1999. Immunohistochemical 
survey of p16INK4A expression in normal human 
adult and infant tissues. Lab Invest. 79:1137–1143.
 18. Zindy, F., Quelle, D.E., Roussel, M.F., and Sherr, C.J. 
1997. Expression of the p16INK4a tumor suppressor 
versus other INK4 family members during mouse 
development and aging. Oncogene. 15:203–211.
 19. Kanavaros, P., et al. 2001. Immunohistochemical 
expression of p53, p21/waf1, rb, p16, cyclin D1, 
p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak 
proteins and apoptotic index in normal thymus. 
Histol. Histopathol. 16:1005–1012.
 20. Lessard, J., and Sauvageau, G. 2003. Bmi-1 deter-
mines the proliferative capacity of normal and leu-
kaemic stem cells. Nature. 423:255–260.
 21. Park, I.K., et al. 2003. Bmi-1 is required for mainte-
nance of adult self-renewing haematopoietic stem 
cells. Nature. 423:302–305.
 22. Molofsky, A.V., et al. 2003. Bmi-1 dependence dis-
tinguishes neural stem cell self-renewal from pro-
genitor proliferation. Nature. 425:962–967.
 23. Lewis, J.L., et al. 2001. The influence of INK4 proteins 
on growth and self-renewal kinetics of hematopoietic 
progenitor cells. Blood. 97:2604–2610.
 24. Meng, A., Wang, Y., Van Zant, G., and Zhou, D. 
2003. Ionizing radiation and busulfan induce 
premature senescence in murine bone marrow 
hematopoietic cells. Cancer Res. 63:5414–5419.
 25. Sherr, C.J. 2000. The Pezcoller lecture: cancer cell 
cycles revisited. Cancer Res. 60:3689–3695.
 26. Phelps, D.E., et al. 1998. Coupled transcriptional 
and translational control of cyclin-dependent 
kinase inhibitor p18INK4c expression during myo-
genesis. Mol. Cell. Biol. 18:2334–2343.
 27. Pagano, M., et al. 1995. Role of the ubiquitin-
proteasome pathway in regulating abundance of 
the cyclin-dependent kinase inhibitor p27. Science. 
269:682–685.
 28. Sherr, C.J., and DePinho, R.A. 2000. Cellular 
senescence: mitotic clock or culture shock? Cell. 
102:407–410.
 29. Ha, T.U., et al. 2000. Mullerian inhibiting substance 
inhibits ovarian cell growth through an Rb-indepen-
dent mechanism. J. Biol. Chem. 275:37101–37109.
 30. Ruas, M., and Peters, G. 1998. The p16INK4a/
CDKN2A tumor suppressor and its relatives. Bio-
chim. Biophys. Acta. 1378:F115–F177.
 31. Uchida, N., and Weissman, I.L. 1992. Searching for 
hematopoietic stem cells: evidence that Thy-1.1lo 
Lin- Sca-1+ cells are the only stem cells in C57BL/
Ka-Thy-1.1 bone marrow. J. Exp. Med. 175:175–184.
 32. Masoro, E.J. 2003. Subfield history: caloric restric-
tion, slowing aging, and extending life. Sci. Aging 
Knowledge Environ. 2003:RE2.
 33. Turturro, A., et al. 1999. Growth curves and sur-
vival characteristics of the animals used in the 
Biomarkers of Aging Program. J. Gerontol. A Biol. 
Sci. Med. Sci. 54:B492–B501.
 34. Yu, B.P., Masoro, E.J., Murata, I., Bertrand, H.A., 
and Lynd, F.T. 1982. Life span study of SPF Fischer 
344 male rats fed ad libitum or restricted diets: 
longevity, growth, lean body mass and disease. 
J. Gerontol. 37:130–141.
 35. Miller, R.A. 2001. Genetics of increased longevity 
and retarded aging in mice. In Handbook of the biol-
ogy of aging. E.J. Masoro and S.N. Austad, editors. 
Academic Press Inc. San Diego, California, USA. 
369–395.
 36. Bartke, A., et al. 2001. Extending the lifespan of 
long-lived mice [letter]. Nature. 414:412.
 37. Coschigano, K.T., Clemmons, D., Bellush, L.L., and 
Kopchick, J.J. 2000. Assessment of growth parame-
ters and life span of GHR/BP gene-disrupted mice. 
Endocrinology. 141:2608–2613.
 38. Miller, R.A., et al. 2002. Gene expression patterns in 
calorically restricted mice: partial overlap with long-
lived mutant mice. Mol. Endocrinol. 16:2657–2666.
 39. Dimri, G.P., et al. 1995. A biomarker that identifies 
senescent human cells in culture and in aging skin 
in vivo. Proc. Natl. Acad. Sci. U. S. A. 92:9363–9367.
 40. Ohtani, N., et al. 2001. Opposing effects of Ets and 
Id proteins on p16INK4a expression during cellu-
lar senescence. Nature. 409:1067–1070.
 41. Huot, T.J., et al. 2002. Biallelic mutations in 
p16(INK4a) confer resistance to Ras- and Ets-
induced senescence in human diploid fibroblasts. 
Mol. Cell. Biol. 22:8135–8143.
 42. Alani, R.M., Young, A.Z., and Shifflett, C.B. 2001. 
Id1 regulation of cellular senescence through tran-
scriptional repression of p16/Ink4a. Proc. Natl. 
Acad. Sci. U. S. A. 98:7812–7816.
 43. Jacobs, J.J., Kieboom, K., Marino, S., DePinho, R.A., 
and van Lohuizen, M. 1999. The oncogene and 
Polycomb-group gene bmi-1 regulates cell prolif-
eration and senescence through the ink4a locus. 
research article
 The Journal of Clinical Investigation   http://www.jci.org   Volume 114   Number 9   November 2004 1307
Nature. 397:164–168.
 44. Hara, E., et al. 1996. Regulation of p16CDKN2 
expression and its implications for cell immortal-
ization and senescence. Mol. Cell. Biol. 16:859–867.
 45. Jacobs, J.J., et al. 2000. Senescence bypass screen 
identif ies TBX2, which represses Cdkn2a 
(p19(ARF)) and is amplified in a subset of human 
breast cancers. Nat. Genet. 26:291–299.
 46. Palmero, I., Pantoja, C., and Serrano, M. 1998. 
p19ARF links the tumour suppressor p53 to Ras. 
Nature. 395:125–126.
 47. Serrano, M., et al. 1996. Role of the INK4a locus 
in tumor suppression and cell mortality. Cell. 
85:27–37.
 48. Sun, L.Q., et al. 2004. Growth retardation and pre-
mature aging phenotypes in mice with disruption of 
the SNF2-like gene, PASG. Genes Dev. 8:1035–1046.
 49. Sharpless, N.E., et al. 2001. Loss of p16Ink4a 
with retention of p19Arf predisposes mice to 
tumorigenesis. Nature. 413:86–91.
 50. Engwerda, C.R., Handwerger, B.S., and Fox, B.S. 1994. 
Aged T cells are hyporesponsive to costimulation 
mediated by CD28. J. Immunol. 152:3740–3747.
 51. Yoshimi, N., et al. 1996. Telomerase activ-
ity of normal tissues and neoplasms in rat colon 
carcinogenesis induced by methylazoxymethanol 
acetate and its difference from that of human 
colonic tissues. Mol. Carcinog. 16:1–5.
 52. Prowse, K.R., and Greider, C.W. 1995. Develop-
mental and tissue-specific regulation of mouse 
telomerase and telomere length. Proc. Natl. Acad. 
Sci. U. S. A. 92:4818–4822.
 53. Wasylyk, C., Bradford, A.P., Gutierrez-Hartmann, 
A., and Wasylyk, B. 1997. Conserved mechanisms 
of Ras regulation of evolutionary related tran-
scription factors, Ets1 and Pointed P2. Oncogene. 
14:899–913.
 54. Paumelle, R., et al. 2002. Hepatocyte growth fac-
tor/scatter factor activates the ETS1 transcription 
factor by a RAS-RAF-MEK-ERK signaling pathway. 
Oncogene. 21:2309–2319.
 55. Tanaka, K., Oda, N., Iwasaka, C., Abe, M., and Sato, 
Y. 1998. Induction of Ets-1 in endothelial cells 
during reendothelialization after denuding injury. 
J. Cell. Physiol. 176:235–244.
 56. Bulavin, D.V., et al. 2004. Inactivation of the Wip1 
phosphatase inhibits mammary tumorigenesis 
through p38 MAPK-mediated activation of 
the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 
36:343–350.
 57. Leung, C., et al. 2004. Bmi1 is essential for cerebel-
lar development and is overexpressed in human 
medulloblastomas. Nature. 428:337–341.
 58. Gil, J., Bernard, D., Martinez, D., and Beach, D. 
2004. Polycomb CBX7 has a unifying role in cel-
lular lifespan. Nat. Cell Biol. 6:67–72.
 59. Kranc, K.R., et al. 2003. Transcriptional coactiva-
tor Cited2 induces Bmi1 and Mel18 and controls 
fibroblast proliferation via Ink4a/ARF. Mol. Cell. 
Biol. 23:7658–7666.
 60. Brunet, A., et al. 2004. Stress-dependent regula-
tion of FOXO transcription factors by the SIRT1 
deacetylase. Science. 303:2011–2015.
 61. Cohen, H.Y., et al. 2004. Calorie restriction pro-
motes mammalian cell survival by inducing the 
SIRT1 deacetylase. Science. 305:390–392.
 62. Mikaelian, I., et al. 2004. Antibodies that label 
paraffin-embedded mouse tissues: a collaborative 
endeavor. Toxicol. Pathol. 32:181–191.
 63. Chimenti, C., et al. 2003. Senescence and death of 
primitive cells and myocytes lead to premature car-
diac aging and heart failure. Circ. Res. 93:604–613.
